دورية أكاديمية

Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.

التفاصيل البيبلوغرافية
العنوان: Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
المؤلفون: Bruzzese, Antonella, Vigna, Ernesto, Terzi, Dario, Greco, Sonia, Martino, Enrica Antonia, Vangeli, Valeria, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Labanca, Caterina, Morelli, Rosellina, Neri, Antonino, Morabito, Fortunato, Zinno, Francesco, Mastroianni, Antonio, Gentile, Massimo
المصدر: Hematology Reports; Sep2023, Vol. 15 Issue 3, p448-453, 6p
مصطلحات موضوعية: VENOUS thrombosis, THROMBOTIC microangiopathies, THROMBOTIC thrombocytopenic purpura, COVID-19 pandemic, PULMONARY embolism, TREATMENT effectiveness
مستخلص: Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening, rare acute thrombotic microangiopathy (TMA), caused by a severe ADAMTS13 deficiency. As the COVID-19 pandemic rapidly spread around the globe, much data about the pathogenicity of this virus were published. Soon after the detection of the first cases of COVID-19, it was clear that there was a wide range of COVID coagulopathy manifestations, such as deep venous thrombosis, pulmonary thromboembolism, and thrombotic microangiopathies. In the literature, little data have been reported about the association between TTP and COVID-19, and the treatment of COVID-19-associated TTP is still under debate. Here we present the case of a 46-year-old woman who developed a COVID-associated TTP, successfully treated with plasma exchange (PEX), steroids, and caplacizumab. [ABSTRACT FROM AUTHOR]
Copyright of Hematology Reports is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20388322
DOI:10.3390/hematolrep15030046